Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Phathom Pharmaceuticals Inc’s stock clocked out at $17.52, down -1.68% from its previous closing price of $17.82. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 0.96 million shares were traded. PHAT stock price reached its highest trading level at $18.175 during the session, while it also had its lowest trading level at $17.1.
Ratios:
To gain a deeper understanding of PHAT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 03, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $23 to $26.
On August 09, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $28.H.C. Wainwright initiated its Buy rating on August 09, 2023, with a $28 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 15 ’24 when Nabulsi Azmi sold 10,901 shares for $11.72 per share. The transaction valued at 127,760 led to the insider holds 240,421 shares of the business.
Henderson Molly sold 4,325 shares of PHAT for $50,689 on Jul 15 ’24. The CFO and CBO now owns 99,447 shares after completing the transaction at $11.72 per share. On Jul 15 ’24, another insider, Curran Terrie, who serves as the President and Chief Executive of the company, sold 33,848 shares for $11.72 each. As a result, the insider received 396,699 and left with 377,734 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 1196433792 and an Enterprise Value of 1274225024. For the stock, the TTM Price-to-Sale (P/S) ratio is 120.61. Its current Enterprise Value per Revenue stands at 128.476 whereas that against EBITDA is -5.055.
Stock Price History:
Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $6.07. The 50-Day Moving Average of the stock is 20.67%, while the 200-Day Moving Average is calculated to be 63.15%.
Shares Statistics:
It appears that PHAT traded 906.51K shares on average per day over the past three months and 1225940 shares per day over the past ten days. A total of 57.97M shares are outstanding, with a floating share count of 37.51M. Insiders hold about 45.07% of the company’s shares, while institutions hold 47.63% stake in the company. Shares short for PHAT as of 1726185600 were 15517989 with a Short Ratio of 17.12, compared to 1723680000 on 14247663. Therefore, it implies a Short% of Shares Outstanding of 15517989 and a Short% of Float of 32.09.
